Essential thrombocytosis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Secondary prevention strategy following essential thrombocytosis include low dose [[aspirin]] | Secondary prevention strategy following essential thrombocytosis include low dose [[aspirin]] therapy. | ||
==Secondary prevention== | ==Secondary prevention== | ||
*Secondary prevention strategy following essential thrombocytosis include low dose aspirin | *Secondary prevention strategy following essential thrombocytosis include low dose aspirin therapy. Use of aspirin may help reduce the risk of complications like: | ||
**[[Stroke]] | **[[Stroke]] | ||
**[[Myocardial infarction]] | **[[Myocardial infarction]] | ||
Latest revision as of 15:47, 17 November 2015
|
Essential thrombocytosis Microchapters |
|
Differentiating Essential thrombocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Essential thrombocytosis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Essential thrombocytosis secondary prevention |
|
Risk calculators and risk factors for Essential thrombocytosis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Soujanya Thummathati, MBBS [2]
Overview
Secondary prevention strategy following essential thrombocytosis include low dose aspirin therapy.
Secondary prevention
- Secondary prevention strategy following essential thrombocytosis include low dose aspirin therapy. Use of aspirin may help reduce the risk of complications like:
- Stroke
- Myocardial infarction
- Transient ischemic attack (TIA)